SmithKline abandons expansion efforts by selling 2 units, shuffling executives

Article Abstract:

British pharmaceutical giant SmithKline Beecham PLC is rethinking its business strategy after a failed move into the managed heakthcare field. The company is selling its clinical laboratory and pharmacy-benefit-management gusinesses as well as shutting down some manufacturing plants. Layoffs totalling 3,000 people are scheduled to occur over the next four years. Meger plans are not in the company's future, although several pharmaceutical firms such as Glaxo are rumored to be interested in SmithKline. The company's strategy is to return to a morepharmaceutical-research-based business.

Strategy & planning, Abstract

---

Cough, cold & allergy remedies (European Markets)

Article Abstract:

This report is about the retail market for allergy and cold remedies and cough in the United Kingdom, Italy, Spain, France and Germany for the period 1995-1999. The report examines the market for child remedies, decongestants, cough and throat remedies, antihistamines and combination products. It also includes profiles of some leading drug companies, sales figures and other statististical data.

United States, Germany, European Union, Organizational history, Production management, Procter & Gamble Co., PG, Warner-Lambert Co., WLA, Boehringer Ingelheim Group

---

Subsector shares: sun care - manufacturer & brand

Article Abstract:

Reckitt & Colman was the leading manufacturer of baby sun care products in 1999.

Statistics, Reckitt and Colman PLC

Similar abstracts:

• Abstracts: Preparing America for compassionate conservatism. The selling of a candidate. The rat-race
• Abstracts: The new handy woman. Not so easy being green at Heinz Canada. CTV's Sopranos takes on Olympics
• Abstracts: Installed in Texas. Investigating space and surfaces. Cultural connections
• Abstracts: Germany reduces tariffs. Taking the right Routes
• Abstracts: Goodyear blames raw material costs for its large loss. Pirelli's net climbs sharply on gains from asset sales

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.